Technical Analysis for RDY - Dr. Reddy's Laboratories Ltd

Grade Last Price % Change Price Change
grade A 42.67 -2.16% -0.94
RDY closed down 2.16 percent on Tuesday, February 25, 2020, on 77 percent of normal volume. It was able to find support at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Flat Down
Historical RDY trend table...

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Stochastic Reached Oversold Weakness 0.00%
Strong but Oversold Other 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Gapped Down Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Dr. Reddy's Laboratories Limited operates as an integrated pharmaceutical company. It operates in three segments: Pharmaceutical services and Active Ingredients (PSAI), Global Generics, and Proprietary Products. The PSAI segment develops active pharmaceutical ingredients (APIs) and intermediaries, which are used as principal ingredients for finished pharmaceutical products. This segment also offers contract research services to biotech and pharmaceutical companies; and manufactures and sells APIs and steroids in accordance with the specific customer requirements. The Global Generics segment produces and markets finished pharmaceutical products as branded formulations or generic finished dosages. This segment also engages in the operation of biologics business. The Proprietary Products segment engages in the discovery and development of new chemical entities for subsequent commercialization and out-licensing. It offers new, synergistic combination, and technology formulations that modifies pharmacokinetics of existing medicines. This segment is also involved in the Company's specialty pharmaceuticals business that includes sales and marketing operations for in-licensed and co-developed dermatology. The company offers its products and services primarily in the areas of gastrointestinal, cardiovascular, pain management, and oncology therapies. It primarily operates in India, the United States, Russia and other countries of the former Soviet Union, Europe, and others. Dr. Reddy's Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India.
Health Pharmaceutical Pharmaceutical Industry Pharmaceuticals Pharmaceutical Products Pharmaceutical Industry In China Pharmaceuticals Policy Pain Management Cnx Nifty Active Pharmaceutical Ingredients Pharmacokinetics Economy Of India Chemical Entities Contract Research Services Dr. Reddy's Laboratories Lupin Limited Oncology Therapies

Is RDY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 46.19
52 Week Low 34.67
Average Volume 191,460
200-Day Moving Average 39.17
50-Day Moving Average 42.54
20-Day Moving Average 44.57
10-Day Moving Average 44.73
Average True Range 0.90
ADX 24.37
+DI 23.66
-DI 35.93
Chandelier Exit (Long, 3 ATRs ) 43.49
Chandelier Exit (Short, 3 ATRs ) 44.55
Upper Bollinger Band 46.13
Lower Bollinger Band 43.02
Percent B (%b) -0.11
BandWidth 6.98
MACD Line 0.45
MACD Signal Line 0.77
MACD Histogram -0.3212
Fundamentals Value
Market Cap 7.07 Billion
Num Shares 166 Million
EPS 1.07
Price-to-Earnings (P/E) Ratio 39.88
Price-to-Sales 2.69
Price-to-Book 3.07
PEG Ratio 0.00
Dividend 0.31
Dividend Yield 0.73%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 44.01
Resistance 3 (R3) 44.10 43.74 43.78
Resistance 2 (R2) 43.74 43.40 43.70 43.71
Resistance 1 (R1) 43.21 43.19 43.03 43.12 43.63
Pivot Point 42.85 42.85 42.77 42.81 42.85
Support 1 (S1) 42.32 42.51 42.14 42.23 41.71
Support 2 (S2) 41.96 42.30 41.92 41.63
Support 3 (S3) 41.43 41.96 41.56
Support 4 (S4) 41.34